Knowledge of the association between body mass index (weight (kg)/height (m) 2 ) and premature death in young adulthood is very limited, especially for specific causes of death. Using the US National Health Interview Survey linked mortality files, the authors examined the relation between body mass index and premature death from all causes, cardiovascular disease (CVD), and cancer among 112,328 persons aged 18-39 years who participated in the National Health Interview Survey in the years 1987, 1988, and 1990-1995. During an average of 16 years of follow-up (ending on December 31, 2006), there were 3,178 deaths: 573 from CVD and 733 from cancer. Hazard ratios and 95% confidence intervals were estimated using multivariate proportional hazards models adjusting for age, gender, race/ethnicity, education, and smoking status. In analyses restricted to participants who had never smoked, the hazard ratios for death from all causes were 1.07 (95% confidence interval (CI): 0.91, 1.26) for overweight participants, 1.41 (95% CI: 1.16, 1.73) for obese participants, and 2.46 (95% CI: 1.91, 3.16) for extremely obese participants, compared with those of normal weight. Monotonically increasing risks for excess body weight were also observed for deaths from cancer and CVD. The associations found in this young cohort were much stronger than those in middle-aged or older populations.
The ongoing obesity epidemic (1, 2) reinforces the importance of understanding the effects of adiposity among young people. The early onset of obesity leads to early disease initiation (3, 4) , putting young people at higher subsequent risk of early mortality. Thus, prevention of obesity at a young age has the potential for great benefits. In particular, it may be easier and more beneficial to prevent obesity (5) or stabilize weight (6) among the young than to reverse it among older people after some of its effects are already present. However, few studies (7) (8) (9) (10) (11) have examined the association of adiposity in adolescence or young adulthood with premature death (before age 60 years), and even fewer studies (10, 11) have assessed multiple categories of excess body weight in relation to cause-specific mortality for major disease categories, because of small numbers of deaths. In fact, to our knowledge, there has been no published study in nationally representative samples of young adults in the United States.
One additional reason for studying the effect of adiposity among the young is that it offers the possibility of reducing the bias that probably afflicts studies of middle-aged and older adults, on whom the great majority of mortality studies have focused. These studies have generally found a body mass index (BMI; weight (kg)/height (m) 2 ) greater than 30, a frequently used measure of adiposity, to be associated with increased all-cause and cardiovascular disease (CVD) mortality (12) (13) (14) (15) (16) (17) (18) . However, findings have been less consistent for slightly elevated BMI and for lower-than-normal BMI (13) (14) (15) (16) (17) (18) (19) (20) (21) . One possible reason for the inconsistent findings is that the effect of adiposity may be biased by the presence of preexisting medical conditions, which can affect body mass as well as mortality and can distort estimates, a bias sometimes called reverse causality (20) . One approach to reduce this bias is to study younger subjects, at ages when few subjects may have preexisting medical conditions and possible resulting weight loss (7) .
Thus, public health importance, a knowledge gap, and the possibility of reducing bias due to reverse causality motivated this study of the relation between BMI in young adulthood and mortality. In particular, we examined the relation between BMI (in 5 categories: <18.5, 18.5-<25.0, 25.0 -<30.0, 30.0 -<35.0, and !35.0) measured in young adulthood and premature death from all causes, CVD, and cancer, using linked mortality files from the National Health Interview Survey (NHIS), a follow-up study of nationally representative samples of the US noninstitutionalized population.
MATERIALS AND METHODS

Study population
This study was based on the NHIS linked mortality files. The NHIS, conducted by the National Center for Health Statistics, is a repeated large-scale household interview survey of a statistically representative sample of the US civilian noninstitutionalized population. The details of NHIS procedures can be found elsewhere (22) . To assure at least 10 years of followup, we used the NHIS survey and underlying cause-of-death data for the years 1987, 1988, and 1990-1995 , in which smoking information was available among randomly selected samples of the entire study populations. We restricted analyses to participants who were 18-39 years of age at the time of the NHIS interview and had complete information on smoking status, age, gender, education, race/ethnicity, height, and weight. We also excluded 668 persons with extreme BMIs (BMI <15.0 or >99.0). We simply deleted those participants with missing or extreme values, because they accounted for less than 5% (4,614/116,942) of the whole study population. The final analysis was based on 112,328 subjects.
Body mass index
BMI was calculated as weight in kilograms divided by the square of height in meters. In each baseline survey, the weight and height of each participant were self-reported (74.1%) or reported by an adult family member (25.9%). BMI was categorized as follows: <18.5, 18.5-<25.0, 25.0-<30.0, 30.0-<35.0, or !35.0. These categories correspond to those defined by the World Health Organization for ''underweight,'' ''normal body weight,'' ''overweight,'' ''obesity I,'' and ''obesity II and III'' (23).
Mortality outcomes
Mortality ascertainment was based primarily upon results from a probabilistic match between NHIS and National Death Index death certificate records. It has been reported that causeof-death information in the National Death Index is accurate for major disease categories (24) and that the matching algorithm yields good agreement (98.5%) (25) . A complete description of the matching method is given elsewhere (26) .
In this study, the primary endpoints were all-cause mortality, death from cancer, and death from CVD. Deaths due to cancer were identified by means of International Classification of Diseases, Ninth Revision (ICD-9), codes 140-208 or International Classification of Diseases, Tenth Revision (ICD-10), codes C00-C97; deaths due to CVD were identified by ICD-9 codes 390-434 and 436-448 or ICD-10 codes I00-I78 (27) .
Follow-up time was calculated from the quarter and year of NHIS interview to the quarter and year of death or the end of follow-up (December 31, 2006), whichever came first. We assumed that a participant's interview or death occurred at the middle of the quarter in which he/she was interviewed or died. 
Statistical analysis
Age-adjusted mortality rates were calculated for each category of BMI through direct standardization to the age distribution of the entire study population with the use of 5-year age categories. To test the association of baseline BMI with premature death from all causes, CVD, and cancer, we fitted Cox proportional hazards regression models adjusting for potential confounders, including gender, age at baseline (years; continuous variable), education (less than high school, high school, or more than high school), race/ ethnicity (white, black, or other), and smoking status (never, former, or current smoker). Additionally, we conducted subgroup analyses among never smokers to eliminate the confounding effect of smoking. BMI was primarily analyzed as a categorical variable, with a reference category of 18.5-<25.0. In supplemental analyses (see Web Table 1 (http://aje. oxfordjournals.org/)), we estimated hazard ratios for a 5-unit increment of BMI. For comparison, we fitted models using both age and amount of time in the study as the time scale. As Pencina et al. (28) reported, almost identical relative risk estimates were obtained for these 2 approaches with adjustment for age at baseline.
We tested for a linear trend in the BMI-mortality association by entering the BMI categories as a continuous variable into the regression models. The significance of interaction between gender and BMI was tested using the Satterthwaite adjusted chi-squared statistic (29) . In sensitivity analysis, we examined the potential impact of preexisting medical conditions by restricting analyses to healthy participants (self-reported ''good,'' ''very good,'' or ''excellent'' health) or additionally excluding the first 5 years of follow-up. We tested the proportional hazards assumption by examining the relation between the scaled Schoenfeld residuals and survival time (30) . No assumption violation was found for any variable included in the analyses.
All analyses were performed using SAS (release 9.2; SAS Institute Inc., Cary, North Carolina) and SUDAAN (release 10.0; RTI International, Research Triangle Park, North Carolina) software, accounting for unequal probabilities of selection, nonresponse, and complex sample design. All P values calculated were 2-sided.
RESULTS
The cohort for this study consisted of 48,746 males and 63,582 females. The mean age at interview was 29.3 years (standard deviation, 6.0). During a median 16.1 years of follow-up, 3,178 deaths were documented, of which 733 were from cancer and 573 were from CVD. All deaths occurred before age 60 years, and the mean age at death was 41.8 years (standard deviation, 6.0). As compared with those with a lower BMI, participants with a higher BMI were older, less likely to be current smokers, less educated, and more likely to be black (Table 1 and Web Table 2 ). The detailed baseline characteristics of participants are presented in Table 1 .
BMI and premature death from all causes
Among all participants, a J-shaped relation between BMI and premature death from all causes was observed, with a decreased risk for being overweight as compared with normal weight (Table 2) . However, when analysis was restricted to never smokers, the hazard ratio for overweight was no longer less than 1, although the 95% confidence interval included 1. Among never smokers, the hazard ratios for premature death from all causes for overweight, obese, and extremely obese participants were 1.07 (95% confidence interval (CI): 0.91, 1.26), 1.41 (95% CI: 1.16, 1.73), and 2.46 (95% CI: 1.91, 3.16), respectively, compared with the normal BMI group (Table 2 and Figure 1) ; a significant trend of increasing risk of premature death with successively higher degrees of excess body mass was noted (P < 0.001). Little or no association between being underweight and premature death from all causes was observed. A slightly different pattern of association between BMI and all-cause mortality was found between male and female never smokers; a J-shaped relation was observed in males, whereas a monotonically increasing relation was observed in females (Table 3 and Figure 2 ).
BMI and premature death from CVD
Excess body weight was strongly related to an elevated risk of premature death from CVD, with a strong trend (P < 0.001) observed in both all participants and never smokers. However, the hazard ratio for each BMI category was much stronger in never smokers than in all participants. Among never smokers, the hazard ratios for overweight, obesity, and extreme obesity were 2.31 (95% CI: 1.50, 3.54), 4.34 (95% CI: 2.71, 6.96), and 8.36 (95% CI: 4.85, 14.40), respectively, compared with normal BMI (Table 2 and Figure 1 ). This monotonically increasing risk of premature CVD death for excess body weight was observed in both male and female never smokers, with comparable magnitudes (Table 3 and Figure 2 ). In analysis of major subgroups of CVD (ischemic heart disease, hypertensive heart disease, and stroke), a particularly strong positive association was observed for hypertensive heart disease (Web Tables 3 and 4) .
BMI and premature death from cancer
Among all participants, cancer mortality among the overweight was associated with lower mortality, in comparison with those of normal weight (Table 2) . Among never smokers, however, the risk of premature death from cancer monotonically increased with increasing BMI (P ¼ 0.001). The hazard ratios for underweight, overweight, obese, and extremely obese never smokers were 0.63 (95% CI: 0.25, 1.61), 1.10 (95% CI: 0.82, 1.47), 1.25 (95% CI: 0.83, 1.88), and 2.28 (95% CI: 1.43, 3.64), respectively, compared with those with a normal-range BMI (Table 2 and Figure 1) . However, when results were stratified by gender, such a monotonic increase in hazard ratios was seen only in female never smokers (Table 3 and Figure 2 ). In male never smokers, extreme obesity was associated with elevated cancer mortality, but moderately increased body weight (overweight and obesity) was not (Table 3 and Figure 2 ). Additional analysis of specific cancer sites (Web Tables 3 and 4) showed that overweight and obesity were associated with a higher risk of premature death from breast cancer (72 deaths).
BMI and premature death from external causes and other causes
For deaths from all external causes combined and from suicide, overweight was associated with a lower risk (Web Tables 3 and 4 ). For ''other causes'' of death, overall a J-shaped association was observed. For acquired immunodeficiency syndrome, overweight and obesity were associated with a lower risk, whereas for diabetes, obesity and extreme obesity were strongly associated with a higher risk.
DISCUSSION
In this large prospective study of a nationally representative cohort of US adults under age 40 years, elevated risk of premature death (before age 60 years) from all causes, CVD, and cancer was monotonically associated with increasing excess body weight among never smokers. A particularly strong association was seen for premature death from CVD. Among never smokers, the risk of premature death from CVD was approximately 2 times higher for overweight participants, 4 times higher for obese participants, and 8 times higher for extremely obese participants, respectively, relative to those whose BMI was in the normal range.
Our findings of increasing risk of CVD death in association with increasing BMI are generally similar to findings from several large cohort studies based on middle-aged or older populations (13) (14) (15) (16) (17) (18) (19) . However, the associations in our study were much stronger than those in any of the other studies (13) (14) (15) (16) (17) (18) (19) . For example, according to results based on followup of subjects in the National Health and Nutrition Examination Survey (19), compared with normal weight, the hazard ratio for CVD death for extreme obesity was approximately 1.5 in persons aged 70 years or older, 2.0 in persons aged d In analyses including all participants, hazard ratios were adjusted for age at baseline (years; continuous variable), gender, race/ethnicity (white, black, or other), education (less than high school, high school, or more than high school), and smoking status (never, former, or current smoker).
e In analyses of never smokers, hazard ratios were adjusted for age at baseline (years; continuous variable), gender, race/ethnicity (white, black, or other), and education (less than high school, high school, or more than high school).
60-69 years, and 2.5 in persons aged 25-59 years. Similarly, attenuated hazard ratios for excess body weight were observed in our supplemental analyses in the older age groups (Web Tables 5-9 ). The weaker association between CVD mortality and BMI at older ages is thought to reflect a real effect modification of age (31, 32) , reverse causality (20) , a survival effect (33) , and reduced validity of BMI for measuring adiposity in older populations (34) . In the only previous study that we found to have examined multiple categories of excess body weight in relation to CVD mortality in young adults (nonsmoking Korean men aged 20-39 years), the risk of death from CVD progressively increased with BMI in a pattern consistent with our results, although overall BMIs in that study were lower (10) . A similar pattern of association between BMI and CVD mortality was also observed in a study carried out among 230,000 Norwegian adolescents (11) . The strong association and monotonically increasing risk of CVD death with increasing excess body weight observed in the present study indicates the importance of weight management at younger ages to reduce premature death from CVD. For premature death from cancer, we found a monotonic increase in risk with increasing BMI (P ¼ 0.001), with a significant 2.3-fold increased risk for extremely obese young adults, among participants who had never smoked. The monotonic relation between BMI and premature death from cancer largely reflects the association for females, since deaths in females accounted for 72.5% (211/291) of all deaths occurring in never smokers. In males, extreme obesity but not moderately increased body weight (overweight and obesity) was related to elevated risk of cancer death. This gender difference may have resulted from the combination of unstable estimates for males (based on 80 deaths), different distributions of cancer sites (Web Table 10 ), and/or a real difference in the association of BMI with mortality for some cancer sites, such as colorectal cancer (35, 36) . Consistent with our results, a monotonically increasing risk of cancer death associated with excess body weight was also observed in several large prospective studies in middle-aged and older populations, such as Cancer Prevention Study II (37) and the Korean Cancer Prevention Study (38) , but not in the National Health and Nutrition Examination Survey study (19) . In 2 previous studies of young adults, investigators reported increased cancer mortality rates for excess body weight as well, but the elevated risks were not statistically significant, perhaps because of small numbers of cancer deaths (7, 39) .
Notably, we observed a higher risk of death from breast cancer for overweight and obesity, even when analysis was restricted to deaths that occurred before 50 years of age. It is generally accepted that obesity is associated with a lower risk of developing premenopausal breast cancer (36) and a poor breast cancer prognosis (40) . However, results regarding the association of BMI with premenopausal breast cancer mortality are less consistent. In a pooled analysis of data from 57 prospective studies, Whitlock et al. (13) found a 15% increased risk of premenopausal breast cancer death (<60 years of age) per 5-unit increase in BMI, while no significant results were observed in the United Kingdom Million Women Study (41) or in a pooled analysis of data from 39 AsiaPacific cohort studies (42) .
For all-cause mortality among never smokers, we observed a slightly higher risk for overweight and moderately increased risks for obesity and extreme obesity, with a significant linear trend (P < 0.001), compared with normal weight. The shape and magnitude of the relation between BMI and all-cause mortality reflects the combined effects of BMI on cause-specific mortality (Web Tables 3 and 4) . Because the distribution of causes of death (Web Table 11 ) and the association of BMI with cause-specific mortality (such as cancer mortality) varied largely between genders, we observed different patterns of association of BMI with all-cause mortality between men and women. A J-shaped relation, with slightly lower risk among the overweight, was observed in male never smokers, whereas the hazard ratios increased monotonically in association with increasing BMI in female never smokers. Notably, when we censored persons who died from acquired immunodeficiency syndrome at the time of death, the gender difference diminished, since we then observed a higher risk ) among never smokers aged 18-39 years, National Health Interview Survey, 1987-1995. Hazard ratios were adjusted for age at baseline (years; continuous variable), gender, race/ ethnicity (white, black, or other), and education (less than high school, high school, or more than high school). Bars, 95% confidence interval. e Hazard ratios were adjusted for age at baseline (years; continuous variable), gender, race/ethnicity (white, black, or other), and education (less than high school, high school, or more than high school).
for being overweight compared with normal weight among male never smokers. Generally similar to our study, previous studies in young adults or adolescents (7, 8, 11) found an elevated risk for excess body weight. Because of differences in study design (demographic characteristics of the study population, age at BMI measurement, and length of followup) and analytical method (BMI classification and smoking adjustment), the magnitude of the association between BMI and all-cause mortality varied across these studies.
In primary analyses, we did not account for preexisting medical conditions, which are expected to be uncommon in young adults (94.2% reported good or excellent health). However, in supplemental analyses, we assessed how these relatively uncommon preexisting medical conditions may have affected our primary results by restricting analyses to self-rated healthy participants with or without additional exclusion of the first 5 years of follow-up. The results of restriction-only analyses were quite similar to those in our ) and gender among never smokers aged 18-39 years, National Health Interview Survey, 1987-1995. Hazard ratios were adjusted for age at baseline (years; continuous variable), gender, race/ethnicity (white, black, or other), and education (less than high school, high school, or more than high school). Bars, 95% confidence interval. primary analyses, except for underweight (Web Table 6 ), but higher hazard ratios for higher BMI groups were observed in restriction-plus-exclusion analyses (Web Table 7 ). The slightly increased risk for underweight in the primary analyses disappeared in both supplemental analyses (no estimates were statistically significant), providing some evidence for the idea that a moderate degree of underweight in young, healthy adults may not be associated with an increased risk of premature death.
It is important to interpret the associations we report in terms of possible causal effects. The potential threats to validity of estimated causal effects of adiposity are many, and include the challenge of defining clearly the effect of interest in a way that corresponds to the study contrast (43), confounding by smoking and preexisting medical conditions, misclassification, and, of course, reverse causality (44) . Although we cannot claim to have fully addressed all of these biases, use of a young, nonsmoking cohort should have reduced the impact of some, including two of those likely to be particularly strong-residual confounding by smoking and reverse causality. The strong associations we found, particularly for CVD, probably reflect a negative impact of excess body weight and other associated aspects of lifestyle on premature mortality, but we emphasize that the exact magnitude is difficult to determine precisely (43) . If the true effect magnitudes were the same as those reported in this study and a weight reduction intervention could reduce the body weight and mortality rate for all overweight (BMI !25.0) young adults to the levels we found among those of normal weight, an estimated 11.0%, 51.1%, and 9.9% of deaths from all causes, CVD, and cancer, respectively, could be prevented among never smokers.
A strength of our study is that this is the first study to have assessed the association of BMI with premature death in a nationally representative cohort of US young adults, in whom preexisting medical conditions are less common and the relation between BMI and mortality is less likely to be importantly affected by reverse causality. Notably, the large sample size allowed us to examine the association between BMI and cause-specific mortality for both moderately and extremely elevated body weight. A limitation of our study is that we calculated BMI from self-reported or proxyreported height and weight. Although the correlation between self-reported and measured BMI values is usually very high (about 90%), underweight people tend to overestimate their BMI and overweight people tend to underestimate their BMI (45, 46) . This dependent measurement error could have biased the relative risk estimates in either direction (46) . The bias is expected to be small for overweight and obese groups, but we should use particular caution in interpreting results for underweight and extreme obesity (46) . Reither and Utz (47) found that proxy-reported BMI tended to underestimate selfreported BMI in the NHIS surveys. We performed additional analyses restricted to participants with self-reported BMI and noted that the hazard ratio for each BMI category changed very little. Another limitation is that only BMI, an indicator of general adiposity, was measured in our study. It would have been preferable to have additional information on waist circumference or waist:hip ratio, two commonly used measures of central adiposity which have been reported to be stronger predictors of death than BMI in some studies. A third limitation of our study is that we did not account for potential confounding effects of alcohol use and physical activity. However, the effects of these two factors should have been small. The association between alcohol use and body weight seems to be weak, especially for young adults (48, 49) , so confounding by this factor is probably unimportant (50) . In a meta-analysis of 49 studies (51), the summary relative risks of all-cause mortality for an elevated BMI were almost identical between studies that included physical activity as a covariate (relative risk ¼ 1.23) and studies that did not (relative risk ¼ 1.24).
In summary, in this large, nationally representative prospective study of young adults, elevated risk of premature death from all causes, cancer, and CVD was strongly associated with increasing excess body weight above the range labeled as normal by the World Health Organization, with the strongest association being observed for CVD. These relative associations were stronger than those usually reported for older adults and were monotonic in nonsmokers, although excess body weight may cause more deaths in older adults because of their high mortality rates.
